All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Steroids during acute COVID-19 do not prevent long COVID in children, large RECOVER study finds

By

Kathryn Hirabayashi,

11d ago· 25 min readenInsight

Summary

This study from the RECOVER Initiative evaluated whether steroid use (dexamethasone, prednisone, prednisolone, methylprednisolone) during acute SARS-CoV-2 infection prevents long COVID in children. Using a retrospective cohort design with target trial emulation methodology, researchers analyzed 854,128 children/youth (768,845 outpatients and 85,283 inpatients). After propensity weighting, the study found that steroids did not reduce the overall risk of post-acute sequelae of SARS-CoV-2 (PASC) in either hospitalized or outpatient children, with one exception: a lower risk of gastrointestinal PASC in hospitalized treated patients (HR: 0.58; 95% CI: 0.39–0.85, p = 0.01). The authors conclude that additional studies are needed to confirm the benefit of steroids and other immunomodulators in preventing long COVID in children.

Source

bskySteroids during acute COVID-19 do not prevent long COVID in children, large RECOVER study findsjournals.plos.org

Key quotes

· 4 pulled
In hospitalized patients, there were no significant treatment differences in the development of PASC in the 1−6 months following acute SARS-CoV-2 infection except for a lower risk of gastrointestinal PASC in treated patients (HR: 0.58; [95% CI: 0.39–0.85], p = 0.01).
In outpatients, no treatment differences were observed in the development of PASC subphenotypes.
Steroids administered during acute SARS-CoV-2 infection did not lead to a decreased risk of PASC, with the exception of gastrointestinal presentations.
Additional studies are needed to confirm the benefit of steroids and other immunomodulators in preventing long COVID.
Snippet from the RSS feed
Background Studies have shown that use of immunomodulators during the acute phase of SARS-CoV-2 infection may decrease development of post-acute sequelae of SARS-CoV-2 (PASC) or long COVID; however, such studies have not been conducted in children. Obje

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.